These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3934158)

  • 1. Identification of N alpha-acetyl-epsilon-(2-propenal)lysine as a urinary metabolite of malondialdehyde.
    McGirr LG; Hadley M; Draper HH
    J Biol Chem; 1985 Dec; 260(29):15427-31. PubMed ID: 3934158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of N-epsilon-(2-propenal)lysine as a major urinary metabolite of malondialdehyde.
    Draper HH; Hadley M; Lissemore L; Laing NM; Cole PD
    Lipids; 1988 Jun; 23(6):626-8. PubMed ID: 3139952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of N-epsilon-(2-propenal)lysine as the main form of malondialdehyde in food digesta.
    Piche LA; Cole PD; Hadley M; van den Bergh R; Draper HH
    Carcinogenesis; 1988 Mar; 9(3):473-7. PubMed ID: 3125998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of N-(2-propenal)ethanolamine as a urinary metabolite of malondialdehyde.
    Hadley M; Draper HH
    Free Radic Biol Med; 1989; 6(1):49-52. PubMed ID: 2492249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein modification by lipid peroxidation products: formation of malondialdehyde-derived N(epsilon)-(2-propenol)lysine in proteins.
    Uchida K; Sakai K; Itakura K; Osawa T; Toyokuni S
    Arch Biochem Biophys; 1997 Oct; 346(1):45-52. PubMed ID: 9328283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary malondialdehyde as an indicator of lipid peroxidation in the diet and in the tissues.
    Draper HH; Polensek L; Hadley M; McGirr LG
    Lipids; 1984 Nov; 19(11):836-43. PubMed ID: 6521608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of malondialdehyde.
    Draper HH; McGirr LG; Hadley M
    Lipids; 1986 Apr; 21(4):305-7. PubMed ID: 3713450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo.
    Dhanakoti SN; Draper HH
    Lipids; 1987 Sep; 22(9):643-6. PubMed ID: 2823043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of malondialdehyde in urine as a 2,4-dinitrophenylhydrazine derivative analyzed with high-performance liquid chromatography.
    Ekström T; Garberg P; Egestad B; Högberg J
    Chem Biol Interact; 1988; 66(3-4):177-87. PubMed ID: 3396120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bound malondialdehyde in foods: bioavailability of the N-2-propenals of lysine.
    Girón-Calle J; Alaiz M; Millán F; Ruiz-Gutiérrez V; Vioque E
    J Agric Food Chem; 2002 Oct; 50(21):6194-8. PubMed ID: 12358501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of N-(2-propenal) serine as a urinary metabolite of malondialdehyde.
    Hadley M; Draper HH
    FASEB J; 1988 Feb; 2(2):138-40. PubMed ID: 3125082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde.
    Draper HH; Hadley M
    Xenobiotica; 1990 Sep; 20(9):901-7. PubMed ID: 2238710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of N-epsilon-(2-propenal)lysine in biological samples after derivatization with diethylethoxymethylenemalonate.
    Girón J; Alaiz M; Vioque E
    Anal Biochem; 1992 Oct; 206(1):155-60. PubMed ID: 1456428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased formation and degradation of malondialdehyde-modified proteins under conditions of peroxidative stress.
    Mahmoodi H; Hadley M; Chang YX; Draper HH
    Lipids; 1995 Oct; 30(10):963-6. PubMed ID: 8538386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that malondialdehyde-derived aminoenimine is not a fluorescent age pigment.
    Itakura K; Uchida K
    Chem Res Toxicol; 2001 May; 14(5):473-5. PubMed ID: 11368543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malondialdehyde excretion by subjects consuming cod liver oil vs a concentrate of n-3 fatty acids.
    Piché LA; Draper HH; Cole PD
    Lipids; 1988 Apr; 23(4):370-1. PubMed ID: 3398725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary aldehydes as indicators of lipid peroxidation in vivo.
    Draper HH; Csallany AS; Hadley M
    Free Radic Biol Med; 2000 Dec; 29(11):1071-7. PubMed ID: 11121713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a biliary metabolite of cisapride.
    Lauwers W; Le Jeune L; Meuldermans W
    Biomed Environ Mass Spectrom; 1988 Mar; 15(6):323-8. PubMed ID: 3378119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of N4-(2-propenal)spermidine as a major reaction product of malondialdehyde and spermidine.
    Niitsu M; Ohya T; Xu XS; Samejima K
    Biol Pharm Bull; 1995 Aug; 18(8):1162-4. PubMed ID: 8535418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.